Interaction and Compatibility Studies in the Development of Olmesartan Medoxomil and Hydrochlorothiazide Formulations under a Real Manufacturing Process

A drug–drug and drug–excipient interactions and compatibilities study was conducted for two fixed-dose combination (FDC) products containing olmesartan medoxomil (OLM)/hydrochlorothiazide (HCT) 20/12.5 mg and OLM/HCT 40/12.5 mg during their development including storage. The study consisted of the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Murillo-Fernández, Mac Arturo, Montero-Zeledón, Ernesto, Abdala-Saiz, Ariadna, Vega-Baudrit, José Roberto, Araya-Sibaja, Andrea Mariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875139/
https://www.ncbi.nlm.nih.gov/pubmed/35214156
http://dx.doi.org/10.3390/pharmaceutics14020424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875139/
https://www.ncbi.nlm.nih.gov/pubmed/35214156
http://dx.doi.org/10.3390/pharmaceutics14020424

Ejemplares similares